期刊文献+

西罗莫司脂质体的体外释放研究 被引量:5

Research on Drug Release in Vitro of Sirolimus Liposome
原文传递
导出
摘要 目的:研究西罗莫司脂质体的体外释放特性。方法:建立反相高效液相色谱法测定西罗莫司含量;采用反透析法,以500mL 20%乙醇为释放介质,考察24 h不同时间西罗莫司脂质体的体外累积释放率,利用药物释放模型方程拟合释放曲线。结果:西罗莫司检测浓度的线性范围为0.5~20 μg.mL^(-1)(r=0.999 8),平均回收率为99.42%,RSD=1.23%;脂质体前4 h的释药速率快,累积释放率为50%,之后释药相对缓慢,24 h的累积释放率为80%,释放曲线符合一级动力学方程。结论:西罗莫司脂质体具有一定缓释效应,其体外释放属于浓度依赖型渗透释药。 OBJECTIVE:To investigate release characteristics of sirolimus liposome in vitro.METHODS:The concentration of sirolimus was determined by RP-HPLC.In vitro release rate of sirolimus liposome within 24 h was investigated by the reverse dialysis method with 20% ethanol 500 mL as medium.Release curve of sirolimus was fitted with drug release model equation.RESULTS:The linear range of sirolimus were 0.5~20 μg.mL^-1(r=0.999 8)with an average recovery of 99.42%(RSD=1.23%).At the first 4 hours of release,sirolimus liposome released rapidly with accumulative release rate of 50%.After that release rate of liposome was slowed down with accumulative rate of 80% in 24 h.The in vitro release curve conformed to the first order equation.CONCLUSION:Sirolimus liposome has delayed release capability,and in vitro drug release of sirolimus liposome is in concentration dependant manner.
出处 《中国药房》 CAS CSCD 北大核心 2010年第25期2369-2371,共3页 China Pharmacy
基金 辽宁省科学技术计划项目(2008225009-4)
关键词 西罗莫司 脂质体 体外释放 反透析法 累积释放率 Sirolimus Liposome Drug release in vitro Reverse dialysis method Accumulative release rate
  • 相关文献

参考文献7

二级参考文献13

  • 1于波涛,张志荣,曾仁杰,苏敏.PEG表面修饰黄芩苷脂质体制备工艺研究[J].西南国防医药,2005,15(1):33-37. 被引量:11
  • 2王超云,傅风华,田京伟,张太平,孙芳,刘珂.黄芩苷对化学性肝损伤的保护作用[J].中草药,2005,36(5):730-732. 被引量:35
  • 3Ashington C. Drug release from microdisperse systems: a critical review [J].Int J Pharm, 1990,58(1) :1 - 12.
  • 4Levy MY, Benita S. Drug release from submicronized O/W emulsion: a new in vitro kinetic evaluation model[J]. Int J Pharm, 1990, 66(1 - 3) :29 - 37.
  • 5Shah N H, Carvajal M T, Patel C I. Self - emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs [J]. Int J Pharm, 1994, 106(1):15-23.
  • 6Stepkowski SM,Chen H,Daloze P.Rapamycin,a potent immunosuppressive drug for vascularized heart,kidney and small bowel transplantation in the rat[J].Transplantation,1991,51 (1):22-26.
  • 7Chen H,Wu J,Xu D,et al.Rapamycin reverse acute heart,kidney and pancreas allograft rejection and prevents accelerated heart allogaft rejection in the rat[J].Transplant Proc,1993,25(1):719-720.
  • 8Kahan BD,Julian BA,Pescovitz MD,et al.Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts:a phase Ⅱ trial 1[J].Transplantation,1999,68 (10):1526-1532.
  • 9美国家用产品公司.口服雷帕霉素配方[P].CN:94116780.1,1995-09-27.
  • 10何心,石跃辉,石春伟,郡修德,井关键,宫崎胜已.黄芩苷在大鼠体内的药动学研究[J].中国药学杂志,1998,33(4):232-234. 被引量:28

共引文献32

同被引文献38

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部